SHANGHAI, China, Oct. 16, 2014 /CNW/ - Emo Capital Corp. (OTCQB: NUVI) (the "Company") is pleased to announce that a memorandum of understanding (MOU) was signed with I-Omni Co. Ltd. of Seoul, South Korea (I-Omni). The MOU is part of an ongoing collaboration to roll out a domestic market distribution of a new line of customized compression wear. It outlines additional terms between the two parties specific to the joint effort to develop a new compression wear clothing line, including sales and support channels in the U.S.
I-Omni partnered with Dong Seoul University to design a new line of custom fitted compression clothing wear that provides support that is particularly useful for people who have body support and or circulation issues. Currently an application for a method and apparatus patent for designing and fitting customized compression wear is being jointly made by I-Omni and Dong Seoul University.
Management commented, " A definitive contract with I-Omni will be next in the works which will solidify our strategy to deliver the highest quality compression wear technology."
The Company is focused on satisfying growing U.S. consumer demand as the compression wear market surpasses the one billion dollar mark in value. Consumers continue to show interest with further innovation and evolvement in compression wear garments. This agreement provides NUVI with another product to help deliver significant company growth by diversifying into other health style related products.
About Emo Capital Corp.
Emo Capital Corp. is focused on health, fitness and beauty care products, produced from all natural ingredients. Our product line consists of naturopathic tablets that help combat lifestyle setbacks including obesity, lack of energy and erectile dysfunction.
Safe Harbor Statement
This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release only speaks as of the date of its distribution.
SOURCE: EMO CAPITAL CORP
For further information: Investor Relations, Tel: 949-419-6588, Email: [email protected], http://www.emocap.com